Rick Winningham Net Worth & Insider Trades

Rick Winningham - CHIEF EXECUTIVE OFFICER, Theravance Biopharma, Inc

As of March 3, 2023

What is Rick Winningham's Net Worth?

The current estimated net worth of Theravance Biopharma, Inc's CHIEF EXECUTIVE OFFICER, Rick Winningham, is estimated to be about $54.03M . Rick Winningham owns about 1,443,364 units of Theravance Biopharma, Inc common stock. In the last 9 years at Theravance Biopharma, Inc, Rick Winningham has sold an estimated value of $5.55M worth.

What is Rick Winningham's Past Insider Trading?

Rick Winningham's largest purchase order was 10,000 units , worth over $245K on August 11, 2017. Rick Winningham's largest sale order was 59,000 units , worth over $559.5K on December 16, 2022. In total, Rick Winningham has made about 25 transactions over 9 years of their time at Theravance Biopharma, Inc. Rick Winningham usually trades in February, with the busiest year in 2022.

Rick Winningham

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Rick Winningham's Salary in 2020?

As CHIEF EXECUTIVE OFFICER of Theravance Biopharma, Inc, Rick Winningham has a total base salary of $1,014,455 . Rick Winningham received compensation valued at about $6,577,746 in 2020 after becoming CHIEF EXECUTIVE OFFICER. The vast majority of their compensation came in the form of other earnings, plans or compensations of $579,646 , other earnings, plans or compensations of $579,646 , and other compensation of $6,045 .

What is Rick Winningham's' Mailing Address?

  • Mailing address is 901 Gateway Boulevard South San Francisco CA 94080 CA

Theravance Biopharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Rick E Winningham 2020 $1,014,455 - $579,646 - $579,646 $6,045 $6,577,746
Rick E Winningham 2019 $983,710 - $473,906 - $473,906 $5,496 $5,932,411
Rick E Winningham 2018 $956,600 $74,767 $690,154 - $690,154 $5,000 $2,522,841
Andrew A. Hindman 2020 $551,608 - $265,278 - $265,278 $5,920 $2,097,950
Andrew A. Hindman 2019 $315,000 $175,000 $216,000 $2,204,956 $216,000 - $3,757,956
Brett Haumann 2020 $572,569 - $213,589 - $213,589 $53,267 $2,742,625
Brett Haumann 2019 $543,047 - $170,000 - $170,000 $42,382 $2,464,280
Brett Haumann 2018 $497,810 $34,125 $315,000 - $315,000 $414,300 $1,517,194
Vijay Sabesan 2020 $407,677 - $760,326 - $760,326 $6,541 $3,077,744
Bradford J. Shafer 2020 $556,321 - $264,999 - $264,999 $6,045 $2,730,565
Bradford J. Shafer 2019 $537,403 - $215,611 - $215,611 $6,983 $2,468,848
Bradford J. Shafer 2018 $518,080 $33,770 $311,726 - $311,726 $5,000 $1,124,537
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1583107/000110465921039784/tm212357-1_def14a.htm

What are Theravance Biopharma, Inc's Past Insider Trades?

Theravance Biopharma, Inc's most recent insider trade came on March 16, 2023 by Richard Graham who sold 2,323 units worth $23.97K . In the last 8 years, insiders at Theravance Biopharma, Inc have sold an estimated value of $150.56M and bought an estimated value of $26.3M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Bradford Shafer, EVP,  Rick Winningham, CHIEF EXECUTIVE OFFICER,  and Philip Worboys, SVP .

Theravance Biopharma, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...